Since Src and FAK were also constitutively active in HK-2 cells it is doubtful whether pathophysiological upregulation of FAK-Src activity is responsible for the elevated NFAT5 activity in RCC cells. The gene discussed is NFAT5; the disease is renal cell carcinoma.